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Summary 
The medicinal leech has been recorded from only 16 sites post-1970 and 13 sites post-1980 
in England, it is noteworthy that 7 of these sites are confined to a small area of Kent and 
another 4 sites are in Cumbria.  The medicinal leech generally lives in ponds and lakes 
which have areas with elevated summer water temperatures. In addition, the species can 
only persist at sites which are visited by suitable vertebrate hosts at times when the leeches 
are actively searching for bloodmeals.   The general decline in availability of wetland 
habitats throughout much of England may have impacted populations of the medicinal leech 
and its potential hosts. 
  The main conservation priorities requiring action include: 
1) Confirming the current distribution of the medicinal leech in England. 
2) Provision of appropriate advice to maintain the remaining populations. 
3) Initiating studies to test: 
a)  the desirability of establishing satellite populations close to potentially vulnerable sites 
where the medicinal leech currently occurs. 
b) the appropriateness of reintroduction at other suitable localities, to secure the continuing 
presence of the medicinal leech in England. 
 
 1.   PRIORITY STATEMENT 
Though once common and widespread, since 1980 the medicinal leech Hirudo medicinalis 
has been recorded at only 13 locations in England, 7 of which are in close proximity, and 
therefore its continued survival in this country is threatened.  The status of the medicinal 
leech is also precarious and declining throughout Europe. Current information suggests that 
the predominately small waterbodies where the medicinal leech occurs are potentially 
vulnerable to changing conditions and some local populations may disappear. 
 The medicinal leech' is protected by inclusion on Schedule 5 of the Wildlife and 
 Countryside Act (1981), appears in the CITES Listing in Appendix II (1987) - Convention 
 on International Trade in Endangered Species of wild Fauna and Flora.  It is listed in 
 Appendix III of the Beme Convention and appears in Annex Va of the Directive on 
 Conservation of Natural Habitats and Wild Flora and Fauna [EEC, Council Directive 92/43 
 (1992)].  The medicinal leech is also listed as a priority species by the UK Biodiversity 
 Steering Group, with the result that a UK Species Action Plan has been drawn up 
 (Biodiversity Steering Group UK (1995)). It was classed as "Rare" in the British Red Data 
 Books (1991). English Nature therefore attach a high priority to the conservation of the 
  medicinal leech. 
 2.   ACTION PLAN OBJECTIVES 
Objective 1:  To confirm the present distribution of the medicinal leech in England by 
surveying specific known sites and waterbodies adjacent to where the medicinal leech has 
been recorded since 1970. Additionally, to collate information on site management relevant 
to the maintenance of the medicinal leech populations at these locations. 
Objective 2:  In the medium term to monitor annually certain selected populations of the 
medicinal leech in England, initially estimating the population sizes and, over time, 
determine whether its continued presence is under threat.  Utilise information on site 
characteristics   and  management  (Objective   1)  to  determine/confirm   the  habitat 
requirements.   Provide site managers/owners with the appropriate management advice 
required to successfully conserve medicinal leech populations. 
Objective 3:  In the long term, identify key sites which can be suitably managed to ensure 
that viable populations of the medicinal leech are maintained in England.  Assess whether 
introduction of the medicinal leech to suitable new sites in England, or reintroduction to 
previously known sites would be appropriate species management measures. 
 3.   LEGAL STATUS 
The medicinal leech is a protected species under the following Acts: 
Schedule 5 of the UK Wildlife and Countryside Act (1981) - this makes it an offence to 
kill, injure, take, possess or sell (alive or dead) medicinal leeches from the wild, and to 
damage, destroy, or obstruct access to their natural habitat.  A special licence from the 
relevant country agency is required for scientific work on this species in the wild. 
CITES Listing on Appendix II (1987) - Convention on International Trade in Endangered 
 Species of wild Fauna and Flora. 
 Permits international trade only where the Scientific Authority of the exporting country is 
 satisfied that the trade will not be detrimental to the survival of the species in the wild - 
 such material to be accompanied by proscribed export permits. 
 EEC Council Directive 92/43, 1992 (Habitats Directive on Conservation of Natural Habitats 
 and Wild Flora and Fauna) lists the medicinal leech under Annex Va ("Animals and plant 
 species of community interest whose taking in the wild and exploitation may be subject to 
 management measures") 
 SSSIs.  A few sites in England are already designated under the Wildlife and Countryside 
 Act (1981) and the sites are managed to conserve the medicinal leech. 
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4.   BIOLOGICAL ASSESSMENT 
4.1   Introduction 
 
The medicinal leech is a comparatively large leech, when fully extended the actively 
swimming, mature individuals are several centimetres in length.  It occurs primarily in 
ponds and lakes with prolific marginal vegetation and high summer water temperatures. 
Access to suitable vertebrate hosts for bloodmeals is necessary. Despite being recorded as 
common in the 19th Century, in 1910 the medicinal leech was declared extinct in the UK. 
This was somewhat presumptive as it has been recorded at about 16 locations since 1970 
in England (Appendix I), 7 of these sites are in very close proximity in Kent (Elliott & 
Tullett,  1992 and Elliott, JM., pers. corn.). The overgrown habitats preferred, cryptic 
behaviour and comparatively high temperature ranges required to promote conspicuous host 
searching activity may have led to small populations of the medicinal leech being 
overlooked. The species has in past centuries been exploited throughout Europe, with an 
annual trade running into millions of leeches, over this period it enjoyed widespread 
medical use in blood-letting. Generally they were collected from the wild and importation 
to England occurred from the continent (Wells, Pyle, & Collins, 1983). More recently, with 
declining  populations,  collection  from the wild has become  greatly restricted  and 
commercial leech fanning is developing (Elliott & Tullett, 1992). 
 
 4.2 Ecology 
 
 
The medicinal leech requires comparatively high water temperatures in summer to initiate 
breeding and individuals can live for up to four years. It may reach maturity in its second, 
third or fourth year depending on site conditions.  Feeding requires active searching for 
prey and searching behaviour has been recorded between April to mid-October (Wilkin, 
1987).  The medicinal leech shows little inclination to move at temperatures below 12°C, 
whilst 50% become active at 19°C and 90% swim vigorously at about 23°C, particularly in 
response to water disturbance (Elliott & Tullett, 1986). Records of host selection are based 
mainly on a few direct observations.  However, at two adjacent sites in Kent, blood-meal 
analysis revealed frogs are important hosts, with smaller contributions from birds and fish. 
The presence at these same sites of large numbers of smooth newt (Triturus vulgaris L.) 
 corpses with bite scars indicated that they are also preyed upon (Wilkin & Scofield, 1990). 
 The introduced marsh frog (Rana ridibunda Pall.) is common at the two Kent sites and its 
 more marked aquatic lifestyle could provide extended opportunities for feeding for the 
 medicinal leech in this situation (Wilkin & Scofield, 1990). The medicinal leech displays 
 long periods of inactivity between feeding and searching for hosts, populations at the Kent 
 sites are generally dominated by small, young individuals and these occur in low numbers 
 at most sites where older leeches usually predominate. 
 Optimum temperature for breeding activity is within the range 25.5-27.5°C, with mating and 
 cocoon production confined to the summer months (Elliott & Tullett, 1992). Sperm can be 
 stored for several months after mating (Wilkin, 1987). Cocoons collected in the wild have 
 contained from 5-15 eggs, whilst in the laboratory up to 30 eggs may be present, the eggs 
 Mann, 1979). 
take 4-10 weeks to hatch depending on temperature (published data reviewed by Elliott & 
Other features of lakes and ponds regarded as important requirements of the medicinal 
leech include moderately eutrophic conditions with extensive stands of waterplants in a 
shallow littoral zone (Whitten, 1990; Bratton & Elliott, 1991) and suitable bankside egg- 
laying sites (Elliott & Tullett,1992).  The medicinal leech cocoons are attached to the 
undersurface of stones or other objects just above the water level at the shoreline, where 
 short-term stability of soil moisture conditions are maintained (Wilkin,1987; Elliott, J.M. 
 pers. corn.). 
 Young medicinal leeches have been reared in captivity from cocoons, using bovine 
 bloodmeals, but establishing continuous laboratory culture can be difficult (Wilkin, 1987) 
 and the optimal field conditions required by young medicinal leeches remain to be 
 established (Elliott & Tullett, 1992).  However, commercial fanning has been attempted 
 since the mid-19th Century (Sawyer, 1981) and a leech farm was established in Swansea 
 in 1984 (Elliott & Tullett, 1992). 
 
4.3 Distribution and population 
 
 Wells and co-authors (1983) provided an extensive review of information on the medicinal 
 leech, attributing its current reduced occurrence to over-collection from the wild, changes 
  in farming methods and general loss of marsh habitat.  Within England, Elliott and Tullett 
  (1992) suggested a reduction in the availability of suitable hosts may exacerbate the 
  problems cited above. The medicinal leech was formerly found widely in Europe, south to 
 the countries bordering the eastern Mediterranean and east to the Ural Mountains (Elliott 
and Tullett, 1982; Wells et al, 1983). The northern limits of its range in Scandinavia may 
have been influenced by repeated introductions, this century the practice has probably 
ceased with the rapid decline in the widespread use of the medicinal leech in blood-letting 
therapy. 
Recorded national declines of the medicinal leech are universal throughout its known range, 
it  has  been  not  been  recorded  from  Ireland  for  over  100  years  and  was  temporarily 
considered extinct in Britain, Holland and Norway, where a few isolated populations now 
persist (Wells et al, 1983). Most records of occurrence in England result from repeat visits 
to known sites and chance encounters.  The overgrown habitats preferred, cryptic behaviour 
and comparatively high temperature ranges required to promote conspicuous host searching 
 activity may have led to small populations of the medicinal leech being overlooked. 
 The medicinal leech was recorded from 7 sites within England by Elliott & Tullett (1982). 
 More recently a sizable but localised population in Kent has been found and studied 
 intensively (Wilkin, 1987).  At most other new English locations, only single individuals, 
 or low densities have been recorded (Wilkin, 1987; Guthrie, 1993; Elliott, J.M. pers corn; 
 Appendix I). The continued presence of the medicinal leech at many of these sites remains 
 to be established.   Within England, nearly half the currently known sites where the 
 medicinal leech occurs are protected, in some way, and therefore the possibility of 
 successfully conserving this species in England must be high (Elliott & Tullett, 1992). 
 Notwithstanding this, particularly small and locally isolated populations are at risk of 
 becoming extinct, leading to a contraction in the present scattered geographic distribution 
 of the medicinal leech in England.  Only one site in England (and the UK) is known to 
 support substantial numbers of medicinal leeches (6000-12000; Wilkin.1987). 
 4.4  Limiting factors 
4.4.1   Habitat                                                      Importance: high 
In England the medicinal leech requires comparatively high water temperatures to breed 
successfully.  Above average temperatures are associated with shallow water in sheltered 
localities of ponds and lakes.  Such conditions are provided by a well developed marginal 
zone of aquatic vegetation. The presence of suitable hosts, at appropriate times, within this 
 marginal zone is necessary for successful blood-feeding to occur, therefore appropriate 
 management of the surrounding land use is also necessary. Shelter from potential predatory 
 fish and birds may be critical.   Factors such as the in-filling of small ponds and changes 
 in pond use (eg development of fisheries and irrigation supply, their reduced level of use 
 by farm stock), may result in the habitats becoming unsuitable for the medicinal leech. 
 The general loss, fragmentation and isolation of suitable wetland habitats throughout much 
 of England will also have been detrimental in the past to the species. 
 4.4.2  Egg laying substrata and the microhabitats of newly-hatched leeches 
                                                          
Importance: to be established 
 Egg cocoons are deposited in damp locations under stones or other objects above the water 
 level at the pond or lake margin.  The cocoons may be susceptible to either drying out, if 
 the water level falls, or the development of anoxic conditions if the water level rises 
  markedly during the incubation period. The availability of suitable stones for sheltering 
 More information on breeding requirements and the ecology of newly-hatched medicinal 
cocoons, at the waters edge, may be important (Elliott, pers corn). 
leeches is required. Most autecological studies show that the mortality rate during this early 
phase of an animal's life cycle can be very high and varies between years and between 
different habitats.   The optimum conditions for young medicinal leeches to grow and 
survive are not known but studies indicate some young are capable of surviving their first 
winter without feeding (Wilkin, 1987). 
4.4.3   Food availability                                                   Importance: high 
  
The medicinal leech requires blood-meals from vertebrates. It depends on the presence of 
 suitable hosts when water temperatures are sufficiently high to trigger an active response 
 to the hosts' movements in the water. The recorded declines in amphibians in England may 
 have impacted the medicinal leech populations and their scope for recovery. The relative 
 importance of waterbirds and fish as hosts remain to be established on a wider scale 
 (Wilkin, 1987).  Recent work has indicated that mammalian blood may not be required in 
 order for the medicinal leech to attain maturity (Wilkin, 1987).  Survival of the medicinal 
 leech at each site depends on its access to suitable hosts, many of which are impacted 
 directly or indirectly by mans activities. 
 
Importance: 4.4.4   Water quality 
medium 
 
There are few data on the water quality requirements of the medicinal leech (apart from 
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temperature requirements) but water quality will indirectly impact the medicinal leech 
through habitat availability, influencing the growth of algae and larger waterplants and also 
the availability of suitable vertebrate hosts. Direct impacts of water quality on egg survival 
in cocoons may be important. 
5.    RESUME OF CONSERVATION ACTION TO DATE 
Internationally the threats to survival of the medicinal leech were highlighted by Sawyer 
 (1981), who recognised the growing industrial demand for hirudin and other useful 
 biochemical extracts. Sawyer called for urgent protection for the species, referring to data 
 compiled for the IUCN Invertebrate Red Data Book (Wells et al, 1983). Subsequently, a 
 range of publications and reports have echoed this concern (eg, Elliott & Tullett, 1984, 
 1992; Wells & Coombes, 1987; Wilkin, 1987; Whitten, 1990; Bratton & Elliott. 1991). The 
 medicinal leech is fully protected in the UK by listing under Schedule 5 of the Wildlife and 
 Countryside Act 1981. However, in a wider context, it is noteworthy that the EEC Council 
 Directive 92/43, 1992 (Directive on Conservation of Natural Habitats and Wild Flora and 
 Fauna, which identifies priority species within Europe) lists the medicinal leech under 
 Annex V ("Animals and plant species of community interest whose taking in the wild and 
 exploitation may be subject to management measures") rather than Annex IV ("...in need 
 of strict protection") (adopted October 1994).  In addition, continuing attempts to control 
 the international trade in medicinal leeches collected from the wild [eg, Turkey (Kasparek, 
  1995)]  highlight the persisting danger from over-exploitation of wild stocks. 
 Within the UK several sites where it has been recorded in the past have been designated 
 as SSSIs or have local Nature Reserve status (Ball, 1994).  Active management, at sites 
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 known to be frequented by the medicinal leech in England, is thought to be confined to the 
sites in Kent. 
The NGO publication "Biodiversity Challenge" (2nd Edition)(1995) provides a UK-wide 
summary species action plan for the medicinal leech, which includes proposals to extend 
reserve status to all known sites in which it occurs, re-establish populations at new sites and 
undertake future research and monitoring. 
The UK Biodiversity Action Plan Steering Group (1995) has broadly similar proposals and 
 highlights current action including: the designation of 12 sites as SSSIs, the creation of a 
 new pond in Wales to increase the availability of medicinal leech breeding habitat and the 
 current development of appropriate species management guidelines for the medicinal leech 
 funded by Scottish Natural Heritage. 
 
6.    PROPOSED ACTION BY ENGLISH NATURE 
6.1   Policy and legislation 
 
Action 1: No action required at this time, the medicinal leech is given complete protection 
under current legislation. 
                               
Priority: low 
 6.2  Site safeguard, land acquisition and management 
  
Action 2:  Review the options for effective future conservation of the medicinal leech in 
 England after a survey to establish more precisely the distribution of the species in 
 England. 
                                           12 
                                   
Priority: high 
Such options might include further SSSI designations, the establishment of new reserves 
and site management agreements. 
 
6.3  Species management, protection and licensing 
Action 3: Notify the appropriate site owners and local wildlife trusts of the presence of the 
medicinal leech, in order that critical habitats are protected from disturbances caused by 
inappropriate management procedures or the collection of leeches.  The vulnerability of 
particular populations to collectors should be considered before the locations of specific 
sites are publicised. 
                                              
Priority: medium 
The maintenance of viable medicinal leech populations may require active management with 
regards to the availability of vertebrate hosts, bearing in mind the recorded declines in 
amphibians in England and changing practices in relation to provision of piped water for 
farm animals.  Where geographically isolated and potentially vulnerable populations are  
present, the possibility oftranslocation and establishment of satellite populations in suitable 
locations nearby should be investigated.  Similarly, at previously known sites, where the 
 medicinal leech no longer occurs, reintroductions should be considered where appropriate 
 conditions and site management can be maintained. 
  
6.4  Advisory 
 Action 4: Information should be provided to landowners that have the medicinal leech in 
 their waters.  This should emphasise the potential vulnerability of the medicinal leech to 
 habitat degradation and the species reliance on continued access to suitable hosts for 
                                             13 
 blood-feeding. 
                                                    
Priority: high 
Many people with access to ponds and lakes are unaware of the whereabouts and ecological 
requirements of the medicinal leech. 
 
6.5  International 
 Action 5:  Any measures taken to conserve the medicinal leech, particularly those within 
 the UK, would benefit from a coordinated approach which utilises new information on 
 effective species management as it becomes available. 
                                             
Priority: high 
 The medicinal leech was formally widely distributed in Europe, although there have been 
 relatively few studies confirming its status.  In the north temperate regions it is recorded 
 as being scarce (Wells et al, 1983).  A recent survey of medicinal leech distribution in 
 Scotland, with advice on appropriate conservation action, is nearing completion (Maitland, 
 1996). Any future study of the English populations of the medicinal leech should include 
 contact with other UK and overseas scientists involved in investigations of the Hirudinea 
 (leech family) and particularly the medicinal leech.  The sites in Kent supporting large 
 populations of the medicinal leech are of international importance. 
 
6.6  Future research and monitoring 
Action 6:   EN should commission work or otherwise support work to confirm the 
distribution of the medicinal leech in England and its habitat requirements during the 
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 different stages of its life cycle. 
                                                           
Priority'.'highi'immediate 
This work should commence with a survey and classification of the 16 sites in England at 
which the medicinal leech has been recorded since 1970 (Appendix I). Records should be 
collated and incorporated in national and UK databases (eg Biological Records Centre, 
Monks Wood). Such a survey could be extended to adjacent, potentially suitable, sites. This 
work would need to be undertaken by suitably trained persons capable of identifying the 
medicinal leech in the field. This data would provide additional information on the habitats 
utilised by the medicinal leech in different localities. 
Action 7:   A suitable monitoring programme needs to be designed and implemented. 
                                              
Priority:High 
Such a monitoring programme would need to be undertaken by suitably trained persons 
capable of identifying the medicinal leech in the field. 
 
6.7  Communications and publicity 
Action 9: Promote the publication and dissemination of information on the medicinal leech 
particularly to owners and managers of sites where it occurs and the local wildlife trusts 
and Environment Agency staff. 
                                             
Priority:High 
Information on the ecology of the medicinal leech would best be presented in accessible 
publications, taking account of the vulnerability of specific sites to unauthorized collection. 
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Action 10:  Promote the development of alternative sources for important biochemical 
derivative, 'currently extracted from  medicinal leeches obtained from the -wild. 
                                             
Priority:High 
Current international trade in medicinal leeches from the wild poses a continuing threat to 
the remaining European populations.
7.    ACTION PLAN REVIEW 
A revision of the Action Plan will be needed after the survey of the medicinal leech 
distribution in England is completed, in order that priority areas containing the most 
important populations can be identified and, if necessary, given some protection. The 
vulnerability of these and other medicinal leech habitats to damage will also need to be 
assessed.   Surveys at approximately five year intervals will enable English Nature to 
monitor any change in the distribution and status of the medicinal leech 
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Consultees:   Dr J.M.Elliott (IFE Windermere), Dr P.S.Maitland (Fish Conservation Centre, 
               Stirling),  Alison Rosser (IUCN),  John.H.Bratton (JNCC). 
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Site Map Ref.           Date of last record Recorder 
1990? 
1990? 
1990? 
1992 
1992 
 
61/073214 
34/418943 
34/462955 
(Ulverston) 
(Ulverston) 
 
Mockmill Sewer, Kent  P.J. Wilkin 
Stonehills Tarn, Cumbria J.M. Elliott 
Jenny Dam, Cumbria  J.M. Elliott 
Minnow Tarn, Cumbria  M. Guthrie 
Leech Tam, Cumbria  M. Guthrie 
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